July 9, 2026
nLIGHT Is Up 28% Today.
The Pentagon just named a winner in directed energy.
First a note from Investor’s Alley
Hi, Tim Plaehn here.
For the first time since the 1990s, foreign central banks have held more gold than U.S. Treasuries.
This milestone shows a significant shift in how global power views safety, liquidity, and trust… making the precious metal price soar to record highs.
But most investors are missing the real opportunity: monthly income from gold.
A quiet $15 fund I recently uncovered is taking advantage of gold’s historic run and delivering massive monthly payouts in the process.
I’m talking about the potential to collect up to $1,152/month.
Click here to discover the gold income breakthrough most investors are missing.
The next payout is just days away. Don’t miss this.
To your income,
Tim Plaehn
Lead Income Strategist, Investors Alley
FEATURED
nLIGHT Is Up 28% Today.
Most investors have never heard of nLIGHT. By the close today, that’s harder to say.
LASR shares surged more than 28% on July 9 after the company announced it had been selected for a Joint Laser Weapon System (JLWS) Other Transaction Authority agreement supporting the U.S. Department of War’s next-generation cruise missile defense program. The initial award is valued at $44 million, with a total program ceiling of up to $627 million, inclusive of follow-on development, integration, and potential production options.
Here’s the thing. This is not a research grant. It is not a study contract.
The JLWS initiative, overseen by the Office of the Under Secretary of War for Research and Engineering, is intended to move directed-energy systems from experimental demonstrations into platforms that can be produced, fielded, and sustained at scale. That distinction matters enormously for anyone trying to understand whether this move is justified or just another defense hype trade.
Why the Move Is More Than One Contract
The context here is critical. The contract comes after the Trump administration requested a $1.5 trillion defense budget from Congress, and Defense Secretary Pete Hegseth told lawmakers that the cost of the Iran War had already risen to $29 billion. Active conflict accelerates procurement timelines in ways that peacetime budgets rarely capture. The Pentagon is not shopping. It is buying.
The Pentagon’s fiscal year 2027 budget request contains $452 million in proposed R&D spending for the development, integration, and assessment of directed energy weapons in support of Golden Dome. That is more than triple the $142 million enacted under the One Big Beautiful Bill Act. A tripling in a single budget cycle is not an incremental shift. It is a strategic reorientation.
And nLIGHT is now formally embedded in that reorientation. The U.S. Army and U.S. Navy together have laid out plans to spend roughly $675.93 million over the next five years on a containerized 150-300 kW Joint Laser Weapon System as part of the military’s broader Golden Dome architecture. The JLWS awarded today is the first contract under that umbrella.
The Biggest Unsolved Problem in Medicine?
Over half a billion people battle osteoarthritis* in a $560B market with no cure. Thankfully, Cytonics may have cracked the code.
They discovered the body already produces a naturally occurring protein that helps protect cartilage, just not enough where it’s needed most. So they developed a therapy that has already been used in more than 10,000 patients, and are now advancing a version that’s 200% more potent toward FDA approval.
If approved, it would be the first therapy to halt cartilage destruction and promote regrowth.
Invest in Cytonics before this month’s deadline.
*Source: The Lancet Rheumatology
This is a paid advertisement for Cytonics Regulation CF offering. Please read the offering circular at https://cytonics.com/
Forward-looking statements are subject to risks and uncertainties. There is no guarantee of performance. Past performance does not predict future results. All investments involve risk, including loss of principal.
The economics of laser weapons versus traditional kinetic systems are genuinely different. Defense officials have long cited the benefits of directed energy systems, including high-speed engagement, low cost-per-shot, and deep magazines. A laser system does not run out of ammunition as long as it has power. That math is what is driving the urgency behind these awards.
The Business Behind the Pop
What separates nLIGHT from other defense plays caught up in a geopolitical trade is the operating data sitting underneath this stock.
nLIGHT posted Q1 2026 revenue of $80.2 million, up 55% year over year, and swung to $0.6 million GAAP net income from an $8.1 million loss in Q1 2025. EPS came in at $0.20, more than doubling the $0.09 consensus estimate. Aerospace and defense led the growth, supported by higher unit sales of directed energy laser products and progress on development contracts. That swing from loss to profit matters because it tells you the fixed-cost leverage is starting to work.
Aerospace and defense revenue in Q1 reached $55.1 million, growing 69% year over year, with record A&D product revenue of $33.1 million up 98% year over year. Nearly doubling the highest-margin segment in a single year is not noise. That is a business in active acceleration.
Gross margin reached 33.1%, up from 26.7% in Q1 2025, with product gross margin hitting a record 43.6% as high-value defense sales accelerate operating leverage. Adjusted EBITDA came in at a record $13.9 million.
The company is not starting from zero on this contract, either. nLIGHT is building on earlier work, including a 300-kilowatt system delivered through the High Energy Laser Scaling Initiative and a 50-kilowatt system supplied under the Army’s Directed Energy Maneuver-Short Range Air Defense program. The Pentagon does not hand $627 million ceiling contracts to companies that have never delivered. It hands them to companies that have.
Sector Breakdown: Who Else Is in This Trade
The Department of War awarded other transaction agreements to both nLIGHT Defense and Lockheed Martin Aculight for the JLWS program, with a combined initial allocation of $86 million and a combined program ceiling of $847 million across both awards. Lockheed gets a piece of the pie but is a company with a market cap north of $100 billion. The $44 million initial award moves nLIGHT far more.
The broader sector picture is also constructive. The global directed energy weapons market is projected to reach $35.32 billion by 2034, growing at a CAGR of 15.11%. High-energy laser platforms led the market with roughly 61% share in 2025. That is exactly where nLIGHT operates.
Other names to watch in the directed energy ecosystem include RTX, Northrop Grumman, and L3Harris, all of which have active programs and all of which benefit from the same budget expansion. But none of them had a single-day catalyst today the way nLIGHT did.
AeroVironment is worth monitoring separately. The company has active counter-UAS programs and competes in some of the same applications. If the Golden Dome budget continues expanding, AVAV could be the next name this theme moves into.
What the Technical Picture Looks Like
LASR rose approximately 28-30% on the day, trading around $74-76, and is up roughly 306% in the past 12 months. A move like that on a single catalyst day is going to attract attention. Volume on LASR today is running significantly above the average 1.25 million shares per day. Options activity has also picked up, consistent with the pattern seen after the Q1 earnings beat in May.
This IPO Could Make SpaceX Look Small (Read before October 6)
A red-hot AI startup just filed to go public — and it’s already valued at nearly $1 trillion. Wall Street legend Marc Chaikin believes a single announcement on October 6 could send that number far higher. He’s found a backdoor way in before the IPO.
The 52-week range runs from approximately $17 on the low end to near $87 on the high end. That kind of range implies significant institutional rotation in and out of the name. Post-announcement, the stock needs to hold above the $70 level on a closing basis to suggest the move is being confirmed rather than faded.
Key levels to watch: $70 as near-term support, $80 and $85 as the next analyst target cluster. Needham raised its price target to $80, maintaining a Buy rating. Stifel raised its target to $85, also with a Buy. Raymond James went further, raising to $100 with a Strong Buy. The consensus across 9 analysts sits at $86.43, with a high estimate of $100. Resistance above $80 is thin, given the stock has rarely traded at these levels historically.
Momentum indicators heading into today were constructive, which is what made the contract announcement so effective as a catalyst. It landed on a technically improving base with institutional buyers who had been waiting for confirmation.
Scenario Modeling
Bull Case: The JLWS program advances on schedule toward operational system demonstrations planned for 2028. nLIGHT captures a majority of the $627 million ceiling value. A&D revenue run rate exceeds $250 million annually by 2027. The stock moves toward analyst targets in the $85-$100 range as revenue visibility improves. This requires successful prototype delivery and no major program delays.
Base Case: nLIGHT executes on the initial $44 million award, progresses into follow-on development phases, and delivers within Q2 guidance of $75-$81 million in revenue. The stock consolidates in the $65-$80 range post-catalyst as the market waits for Q2 results to confirm the momentum. Gross margins hold above 30%. The directed energy theme continues to attract institutional interest but the stock’s premium valuation moderates near-term multiple expansion.
Bear Case: The Pentagon’s transition from prototype to production, historically a failure point for directed energy programs, stalls. Despite their promise, the Pentagon has historically struggled to transition directed energy platforms from research and development to larger-scale production and fielding. If program timelines slip or the industrial segment continues declining faster than expected, the stock’s elevated price-to-sales multiple becomes difficult to defend. A reversal below $65 would signal the move is being unwound rather than institutionally held.
Active Trader Strategy Framework
A 28% single-day move on a defense contract changes the risk math meaningfully. The position risk for traders who chased the open is very different from those who owned the stock going in. That asymmetry deserves recognition.
For active traders, the tactical question is whether this is a momentum continuation trade or a catalyst that pulls forward demand. The stock has surged roughly 306% over the past 12 months as defense spending on directed energy systems accelerates. Multi-hundred-percent moves do not always reverse cleanly. Sometimes the new contract unlocks a higher structural floor as institutional ownership expands.
Watch the post-announcement volume pattern over the next three to five sessions. High volume on green days following a catalyst suggests accumulation. High volume on red days suggests profit-taking from earlier holders who used the announcement as an exit. The distinction will tell you more than price action alone.
Risk management consideration: the stock’s beta is elevated, and with the US-Iran conflict still active, any geopolitical de-escalation could reduce the urgency premium embedded in defense names generally. Position sizing should reflect that macro overlay.
The next data point that matters is Q2 earnings, likely mid-to-late August, when investors will see whether the A&D revenue trajectory held through the second quarter and whether the JLWS contract begins contributing to backlog guidance. That number, not today’s contract announcement, will determine whether the stock is priced correctly at these levels.
Bitcoin Got the Idea Right. It Got the Backing Wrong.
Bitcoin proved millions want money no government can print. But it’s backed by nothing but belief.
What happens when you keep everything it got right — and back it with real, verified gold? You find out July 8.
The Bigger Picture
What nLIGHT’s move today actually represents is the market beginning to price something it has been skeptical about for years: that directed energy weapons are graduating from science projects into fielded military hardware. The difference between a demonstration program and a production contract is everything for a company this size.
Pentagon officials are working to advance directed energy weapons from experimental prototypes to combat-ready, deployable defense systems, and nLIGHT has been selected as a key participant in this transformation. That framing is deliberate. The Pentagon does not use language like that for programs it is not serious about.
Whether the stock holds the move or fades it, the message embedded in today’s contract is harder to ignore: the Pentagon wrote a check, named a winner, and pointed toward a budget line that is tripling. That is not a theory. That already happened.
For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.
